Clovis Oncology, Inc. CLVS
0.08 +0.08
Day range unavailable
52-week range unavailable
Discussion (3636)
Sign in to join the discussion
- Better get some powder to LOAD up in this. IMO, an EPIC run is coming. These current drugs could hold a street value in excess of $700B, IMO.
- Clovis Oncology, Inc. (NASDAQ:CLVS), announced today that two abstracts featuring non-clinical data from studies evaluating FAP-2286 and Rubraca and a Trial-in-Progress poster detailing the Phase 1 portion of the LuMIERE study will be presented at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2022, being held April 8-13, 2022, in New Orleans.
- PURE FUCKING MM MANIPULATION. Those MOTHER FUCKERS
- This MOTHER FUCKER. Unbelievable
- In the meantime, you can expect the SHIT EATING MMs here to continue their games
- MAX SURGE will occur when retail floods, tutes AMP their loading, CALLs are executed, and, the stock gets SQUEEZED by shorts— ALL AT THE SAME TIME
- I will go ahead and call it.. $6.75+, by the end of NEXT week
- a betting trader would put money on the FACT that groups like WSB are loading CALLS here, for a coordinated RUN on the stock
- This is EXACTLY the same activity that occurred before CLVS DOUBLED last week. Expecting BIG ASS move UP in price
- CALL OPTION volume has SKY ROCKETED on CLVS. Someone KNOWS something!